IBBI Registered Valuer Entity IBBI/RV-E/02/2020/123 · IRDAI category A surveyors+91 97370 33380bd@rakeshnarula.com
CallGet proposal
Chemicals & Pharma playbook

Acquiring an API manufacturer: valuing products, approvals and plants

Last updated

An API maker is worth its products, its approvals and the plant that meets the rules. We run a DCF on what each product should earn. We check it against deal multiples. Then we adjust for risk from the regulator, such as a pending inspection or an import alert.

How it usually unfolds

A mid-sized pharma firm wants a sure supply of key molecules. It plans to buy an API maker with approvals in regulated markets.

We work out sales product by product. We weigh where each approval stands. We ask how much of the sales rest on a few buyers. We read the past inspection reports and look at the state of the plant. Then we check our figure against recent pharma deals.

The buyer gets a value range. It sees the risks from the regulator that could move it. It also gets a list of points to close before it signs.

Illustrative scenario drawn from the kinds of mandates RNC handles. It does not describe a specific client.

What changes the value

Decision pointWhy it matters
Regulatory statusA pending inspection or a warning letter is a real risk.
Product concentrationRelying on a few molecules raises risk.
Capacity complianceCapacity that meets the rules is worth more than nameplate capacity.

What to have ready

  • Revenue and margin data for each product
  • Regulatory approvals and inspection history
  • Plant and equipment details
  • Customer contracts
FAQ

Questions clients ask us

How do approvals affect pharma valuation?

Approvals for regulated markets open up sales at better margins. They are one of the main things that drive value.

Which multiples are used?

EV/EBITDA and EV/sales. We take them from listed firms and deals like this one. Then we adjust for size and risk.

Get a quote

Request a chemicals & pharma valuation proposal

Tell us what needs valuing and why. You will hear back from a partner, not a sales desk.

  • Scoped proposal with fee and timeline, usually within one business day
  • Conflict check and NDA before any data changes hands
  • Reports signed under IBBI registration IBBI/RV-E/02/2020/123

Tell us about the assignment

Takes under a minute. All fields help us scope accurately.

    Service interested in *

    Your details stay confidential and are used only to prepare your proposal.